BAD/BCL-X_L heterodimerization leads to bypass of G0/G1 arrestCHATTOPADHYAY, Anuja; CHIANG, Chi-Wu; YANG, Elizabeth et al.Oncogene (Basingstoke). 2001, Vol 20, Num 33, pp 4507-4518, issn 0950-9232Article

Cleavage of Bcl-2 in oxidant- and cisplatin-induced apoptosis of human melanoma cellsDEL BELLO, Barbara; VALENTINI, Marta A; ZUNINO, Franco et al.Oncogene (Basingstoke). 2001, Vol 20, Num 33, pp 4591-4595, issn 0950-9232Article

Independent control of cell survival by Raf-1 and Bcl-2 at the mitochondriaZHONG, J; TROPPMAIR, J; RAPP, Ulf R et al.Oncogene (Basingstoke). 2001, Vol 20, Num 35, pp 4807-4816, issn 0950-9232Article

Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAILBELKA, C; SCHMID, B; MARINI, P et al.Oncogene (Basingstoke). 2001, Vol 20, Num 17, pp 2190-2196, issn 0950-9232Article

Apoptose et sénescence = Apoptosis and agingPHELOUZAT, M.-A; QUADRI, R. A; PROUST, J. J et al.MS. Médecine sciences. 1995, Vol 11, Num 6, pp 894-900, issn 0767-0974Article

Bcl-2 family proteinsREED, J. C.Oncogene (Basingstoke). 1998, Vol 17, Num 25, pp 3225-3236, issn 0950-9232Article

Bad est-elle la protéine cible des facteurs de survie ? = Is bad the target of survival factors ?DE LA COSTE, A; PERRET, C.MS. Médecine sciences. 1997, Vol 13, Num 3, pp 384-386, issn 0767-0974Article

Analysis of Bcl-2 protein expression in choroidal melanomasHUSSEIN, M. R.Journal of clinical pathology. 2005, Vol 58, Num 5, pp 486-489, issn 0021-9746, 4 p.Article

Nitric oxide donor-induced p53-sensitive cell death is enhanced by Bcl-2 reduction in human neuroblastoma cellsKITAMURA, Y; KAMOSHIMA, W; SHIMOHAMA, S et al.Neurochemistry international. 1998, Vol 32, Num 1, pp 93-102, issn 0197-0186Article

Interaction between the C. elegans cell-death regulators CED-9 and CED-4SPECTOR, M. S; DESNOYERS, S; HOEPPNER, D. J et al.Nature (London). 1997, Vol 385, Num 6617, pp 653-656, issn 0028-0836Article

Loss of proapoptotic Bcl-2-related multidomain proteins in primary melanomas is associated with poor prognosis. CommentaryLEVERKUS, Martin; GOLLNICK, Harald; EBERLE, Jürgen et al.Journal of investigative dermatology. 2006, Vol 126, Num 6, issn 0022-202X, 1212-1214,1366-1371 [9 p.]Article

Autophagie et destruction des lymphocytes T CD4 par le VIH-1 = Autophagy and CD4 T lymphocyte destruction by HIV-1ESPERT, Lucile; DENIZOT, Mélanie; GRIMALDI, Marina et al.MS. Médecine sciences. 2006, Vol 22, Num 8-9, pp 677-678, issn 0767-0974, 2 p.Article

Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and deathWEI, Michael C; ZONG, Wei-Xing; CHENG, Emily H.-Y et al.Science (Washington, D.C.). 2001, Vol 292, Num 5517, pp 727-730, issn 0036-8075Article

Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition poreRAVAGNAN, L; MARZO, I; ZHIHUA XIE et al.Oncogene (Basingstoke). 1999, Vol 18, Num 16, pp 2537-2546, issn 0950-9232Article

Bcl-2 inhibits cell death of serum-free mouse embryo cells caused by epidermal growth factor deprivationLOO, D. T; BRADFORD, S; HELMRICH, A et al.Cell biology and toxicology. 1998, Vol 14, Num 6, pp 375-382, issn 0742-2091Article

Apoptosis is accompanied by changes in Bcl-2 and Bax expression, induced by loss of attachment, and inhibited by specific extracellular matrix proteins in mammary epithelial cellsMERLO, G. R; CELLA, N; HYNES, N. E et al.Cell growth and differentiation. 1997, Vol 8, Num 2, pp 251-260, issn 1044-9523Article

Cell line dependence of Bcl-2-induced alteration of glutathione handlingSCHOR, N. F; RUDIN, C. M; HARTMAN, A.-R et al.Oncogene (Basingstoke). 2000, Vol 19, Num 3, pp 472-476, issn 0950-9232Article

The Bcl-2 protein family : Arbiters of cell survival : ApoptosisADAMS, J. M; CORY, S.Science (Washington, D.C.). 1998, Vol 281, Num 5381, pp 1322-1326, issn 0036-8075Article

Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helixWALENSKY, Loren D; KUNG, Andrew L; ESCHER, Iris et al.Science (Washington, D.C.). 2004, Vol 305, Num 5689, pp 1466-1470, issn 0036-8075, 5 p.Article

Bcl-2 expression delays hepatocyte cell cycle progression during liver regenerationVAIL, Mary E; CHAISSON, Michelle L; THOMPSON, James et al.Oncogene (Basingstoke). 2002, Vol 21, Num 10, pp 1548-1555, issn 0950-9232Article

Intracellular mechanisms of TRAIL : apoptosis through mitochondrial-dependent and -independent pathwaysSULIMAN, Ayoub; LAM, Arh; DATTA, Rakesh et al.Oncogene (Basingstoke). 2001, Vol 20, Num 17, pp 2122-2133, issn 0950-9232Article

N-terminal domain of BARF1 gene encoded by Epstein-Barr virus is essential for malignant transformation of rodent fibroblasts and activation of BCL-2WANG SHENG; DECAUSSIN, Gisèle; SUMNER, Stéphanie et al.Oncogene (Basingstoke). 2001, Vol 20, Num 10, pp 1176-1185, issn 0950-9232Article

Bcl-2 accelerates multistep prostate carcinogenesis in vivoBRUCKHEIMER, Elizabeth M; BRISBAY, Shawn; JOHNSON, Dennis J et al.Oncogene (Basingstoke). 2000, Vol 19, Num 46, pp 5251-5258, issn 0950-9232Article

Bax membrane insertion during Fas(CD95)-induced apoptosis precedes cytochrome c release and is inhibited by Bcl-2MURPHY, K. M; STREIPS, U. N; LOCK, R. B et al.Oncogene (Basingstoke). 1999, Vol 18, Num 44, pp 5991-5999, issn 0950-9232Article

Bcl-2 expression delays mammary tumor development in dimethylbenz(a)anthracene-treated transgenic miceMURPHY, K. L; KITTRELL, F. S; GAY, J. P et al.Oncogene (Basingstoke). 1999, Vol 18, Num 47, pp 6597-6604, issn 0950-9232Article